Advertisement

4 Responses

  1. Jessica Apple
    Jessica Apple April 27, 2012 at 7:10 am | | Reply

    Nice video. I had a great interview with the Oramed folks a few months ago: http://asweetlife.org/a-sweet-life-staff/featured/insulin-in-a-capsule-the-promising-development-of-oral-insulin/24033/

  2. John
    John April 27, 2012 at 11:48 am | | Reply

    This stuff all sounds great, and if they are a public company it helps boost their stocks, but the all important questions are WHEN? & For Who?

    My thoughts, don’t report on it if there’s no answer to the aforementioned questions.

    It’s nothing but a tease…. And then, the big let down comes since it will most likely fail like 99% of the ‘breakthroughs’ reported.

    I don’t need to ‘Hope’ any longer. I need real world bedside results.

  3. The Insulin Pill Gets Real? A Chat with Oramed’s CEO « DiabetesNews

    [...] again whenever we take an injection or show off our insulin pump to family, friends, or strangers. Read more Share this:FacebookStumbleUponRedditDiggEmailPrint Category : Featured, Glucose and [...]

  4. Bob S
    Bob S May 1, 2012 at 9:23 am | | Reply

    I get depressed every time I read about the research effort going into changing insulin delivery. It’s a hugely expensive solution to the wrong problem. Injecting insulin = no big deal for 99.9% of diabetics. Unworkably slow insulins, poorly developing CGM technology, awful dietary advice from most sources = bad quality of life for 99.9% of diabetics. But no, let’s put the effort into not having to inject, basically because it makes non diabetics pity children who inject or don’t like it. How about the hassle of children who are hypo/ hyper far more than they should be, and on a path to guaranteed complications – i’d take (or get my diabetic kid to take) 100000 times more injections than I do for the rest of my life in a heartbeat to get a decent CGM to tell me (or them) what I need accurately (not where i was half an hour ago +/- 20%) or insulin that could work (& clear the system) with something closer to the curve of natural insulin… wrong problem, wrong focus, wrong use of research cash.

    Why does it seem so disproporitionately about avoiding injections & automation of delivery, instead of improving clinical effect and patient knowledge?

Leave a Reply